Progress of Pharmacological Approaches in Parkinson's Disease.

Zeuner, Kirsten E; Schäffer, Eva; Hopfner, Franziska; Brüggemann, Norbert; Berg, Daniela

Zeuner, Kirsten E; Schäffer, Eva; Hopfner, Franziska; Brüggemann, Norbert; Berg, Daniela.

Afiliação

Zeuner KE; Department of Neurology, Christian-Albrechts-University Kiel, Kiel, Germany.
Schäffer E; Department of Neurology, Christian-Albrechts-University Kiel, Kiel, Germany.
Hopfner F; Department of Psychiatry and Psychotherapy, Hospital of the University of Munich, Munich, Germany.
Brüggemann N; Department of Neurology, University of Lübeck, Lübeck, Germany.
Berg D; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

Clin Pharmacol Ther ; 105(5): 1106-1120, 2019 05.

Article em En | MEDLINE | ID: mdl-30661251

Assuntos

Antiparkinsonianos/uso terapêutico; Doença de Parkinson/tratamento farmacológico; Animais; Antiparkinsonianos/farmacologia; Dopaminérgicos/uso terapêutico; Humanos; Fármacos Neuroprotetores; Doença de Parkinson/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Antiparkinsonianos Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google